Filip Steinbauer

Field of research

  • Investigating machine learning in preclinical pharmacokinetics and pharmacodynamics

Curriculum vitae

Since 07/2023: Doctoral student ML in preclinical modeling and simulation, Bayer AG, Berlin

11/2022 – 06/2023: Master thesis, Bayer AG, Berlin

06/2022 – 09/2022: Internship, Bayer AG, Wuppertal

09/2021 – 06/2023: Pharmaceutical Modelling (M.Sc.) studies, Uppsala University, Uppsala, Sweden

02/2021 – 08/2021: Internship, Roche Diagnostics, Penzberg

11/2020 – 01/2021: Student assistant, Walther-Straub-Institut LMU, Munich

02/2020 – 10/2020: Bachelor thesis, Walther-Straub-Institut LMU, Munich

08/2019 – 01/2020: Internship, Walther-Straub-Institut LMU, Munich

10/2016 – 08/2021: Bioengineering studies (B.Eng.), Munich University of Applied Sciences, Munich

06/2015: Abitur, Viscardi Gymnasium, Fürstenfeldbruck

Publications

Manuscripts

Zaher O, Selzer D, Loer H, Neuschwender F, Steinbauer FF, Dings C, Rüdesheim S, Bragazzi NL, Walle N, Doerr AA, Peters B, Schwab M, Laschke MW, Menger MD, Schmidt PH, Meyer MR, Schaefer N, Lehr T. Physiologically based pharmacokinetic modeling as a translational tool in forensic toxicology: from pig to human synthetic cannabinoid toxicokinetics using 5F-Cumyl-P7AICA and its major metabolite as a case study. Arch Toxicol. 2026. doi:10.1007/s00204-026-04613-7

Steinbauer F, Lehr T, Reichel A. Exploring the Potential of Adaptive, Local Machine Learning in Comparison to the Prediction Performance of Global Models: A Case Study from Bayer’s Caco-2 Permeability Database. Journal of Chemical Information and Modeling. 2024. doi: 10.1021/acs.jcim.4c01083

Contact information

Filip Steinbauer

Preclinical M&S
Bayer AG
Müllerstr. 178
13353 Berlin

filip.steinbauer(at)bayer.com